CORC

在结果中检索

CORC

浏览/检索结果: 共36条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial 期刊论文
2019, 卷号: 120, 页码: 20-30
作者:  Robson Mark;  Ruddy Kathryn J;  Im Seock-Ah;  Senkus Elżbieta;  Xu Binghe
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer 期刊论文
2019, 卷号: 30, 期号: 4, 页码: 558-566
作者:  Robson, M. E.;  Tung, N.;  Conte, P.;  Im, S-A;  Senkus, E.
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Li, Wei;  Im, Seock-Ah;  Xu, Binghe;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe;  Masuda, Norikazu
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Information Technologies in the Process of Inter-Faculty Subject Olympiad in the Russian Language and Culture of Speech 期刊论文
Astra Salvensis - revista de istorie si cultura, 2018, 卷号: Vol.VI Suppl 1, 页码: 617-624
作者:  GalinaV.Korneva;  ZinaidaM.Kim;  TatyanaV.Goncharova;  IrinaViktorovnaKostyuk;  LyudmilaV.Kozlova
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/24
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
EUROPEAN JOURNAL OF CANCER, 2018-04-01
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace